Three of the total 103 research projects on the list involve researchers at KI: AI for early detection and prognosis of ...

H.C. Wainwright analyst Joseph Pantginis says Leerink this morning downgraded Compass Therapeutics (CMPX) saying the company’s biliary ...

Fully enrolled the Phase 2/3 trial of lead asset CTX-009 (DLL4 and VEGF-A bispecific antibody) in patients with biliary tract cancers (BTC); top-line data readout is on track for the end of the first ...

Women have an increased global burden of gallbladder and biliary tract cancer (GBTC) compared with men, according to a study in the Journal of Gastroenterology and Hepatology.

Eisai has filed for approval in Japan for tasurgratinib, its small-molecule fibroblast growth factor (FGF) receptor inhibitor, as a treatment for biliary tract cancers with FGFR2 gene fusion ...

MSD’s PD-1 inhibitor Keytruda has been approved by the FDA as a treatment for locally advanced unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy, the first ...

Compass Therapeutics, Inc. ( (CMPX) ) has released its Q3 earnings. Here is a breakdown of the information Compass Therapeutics, Inc. presented ...

In your diet, you want a good amount of water (roughly 2 litres daily) and need to strike a balance between protein and ...

2022;11(2):717-729. doi: 10.21037/apm-22-87 Kato A, Shimizu H, Ohtsuka M, et al. Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with ...

“I got an ultrasound, and it showed a solid mass.” Follow-up tests revealed Towle had bile duct cancer, also called cholangiocarcinoma, a rare cancer that forms on the network of tubes that ...